It utilizes a tumor-specific promoter (TSP) to control a transgene encoding tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) and the viral E1A gene, which play a role in tumor necrosis and p53-dependent apoptosis, respectively. This evidence concerns the gene DHTKD1 and neoplasm.